These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1934164)

  • 21. Novel euglycemic and hypolipidemic agents. 1.
    Lohray BB; Bhushan V; Rao BP; Madhavan GR; Murali N; Rao KN; Reddy AK; Rajesh BM; Reddy PG; Chakrabarti R; Vikramadithyan RK; Rajagopalan R; Mamidi RN; Jajoo HK; Subramaniam S
    J Med Chem; 1998 May; 41(10):1619-30. PubMed ID: 9572887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and Evaluation of the Hypoglycemic and Hypolipidemic Activity of Sulfonamide-benzothiazole Derivatives of Benzylidene-2,4- thiazolidnedione.
    Ahmadi A; Khalili M; Sohrabi L; Delzendeh N; Nahri-Niknafs B; Ansari F
    Mini Rev Med Chem; 2017; 17(8):721-726. PubMed ID: 27903228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and hypoglycemic activity of some substituted flavonyl thiazolidinedione derivatives--fifth communication: flavonyl benzyl substituted 2,4-thiazolidinediones.
    Tunçbilek M; Bozdağ-Dündar O; Ayhan-Kilcigil G; Ceylan M; Waheed A; Verspohl EJ; Ertan R
    Farmaco; 2003 Jan; 58(1):79-83. PubMed ID: 12595040
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents.
    Shakour N; Sahebkar A; Karimi G; Paseban M; Tasbandi A; Mosaffa F; Tayarani-Najaran Z; Ghodsi R; Hadizadeh F
    Bioorg Chem; 2021 Oct; 115():105162. PubMed ID: 34314919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and antidiabetic activity of novel 2,4-thiazolidinedione derivatives containing a thiazole ring.
    Bozdağ-Dündar O; Ceylan-Unlüsoy M; Verspohl EJ; Ertan R
    Arzneimittelforschung; 2006; 56(9):621-5. PubMed ID: 17063636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on antidiabetic agents. I. Synthesis of 5-[4-(2-methyl-2-phenylpropoxy)-benzyl]thiazolidine-2,4-dione (AL-321) and related compounds.
    Sohda T; Mizuno K; Tawada H; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3563-73. PubMed ID: 7160011
    [No Abstract]   [Full Text] [Related]  

  • 27. Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice.
    Weinstock RS; Murray FT; Diani A; Sangani GA; Wachowski MB; Messina JL
    Pharmacology; 1997 Apr; 54(4):169-78. PubMed ID: 9211562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic insulin resistance in KKA(y) mice and its amelioration by pioglitazone do not involve alterations in phospholipase C activity.
    Bleasdale JE; Swanson ML
    Biochim Biophys Acta; 1993 Jun; 1181(3):240-8. PubMed ID: 8391325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on antidiabetic agents. II. Synthesis of 5-[4-(1-methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and its derivatives.
    Sohda T; Mizuno K; Imamiya E; Sugiyama Y; Fujita T; Kawamatsu Y
    Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3580-600. PubMed ID: 7160012
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel tricyclic-alpha-alkyloxyphenylpropionic acids: dual PPARalpha/gamma agonists with hypolipidemic and antidiabetic activity.
    Sauerberg P; Pettersson I; Jeppesen L; Bury PS; Mogensen JP; Wassermann K; Brand CL; Sturis J; Wöldike HF; Fleckner J; Andersen AS; Mortensen SB; Svensson LA; Rasmussen HB; Lehmann SV; Polivka Z; Sindelar K; Panajotova V; Ynddal L; Wulff EM
    J Med Chem; 2002 Feb; 45(4):789-804. PubMed ID: 11831892
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T; Sugiyama Y; Taketomi S; Sohda T; Kawamatsu Y; Iwatsuka H; Suzuoki Z
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Studies on compounds with antioxidant activity--development of hypoglycemic agents, troglitazone (CS-045)].
    Yoshioka T; Fujita T
    Yakugaku Zasshi; 1997 Sep; 117(9):597-610. PubMed ID: 9357328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, hypoglycemic and hypolipidemic activities of novel thiazolidinedione derivatives containing thiazole/triazole/oxadiazole ring.
    Mohammed Iqbal AK; Khan AY; Kalashetti MB; Belavagi NS; Gong YD; Khazi IA
    Eur J Med Chem; 2012 Jul; 53():308-15. PubMed ID: 22575535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase.
    Kobayashi M; Iwanishi M; Egawa K; Shigeta Y
    Diabetes; 1992 Apr; 41(4):476-83. PubMed ID: 1318856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid abnormalities in tissues of the KKAy mouse: effects of pioglitazone on malonyl-CoA and diacylglycerol.
    Saha AK; Kurowski TG; Colca JR; Ruderman NB
    Am J Physiol; 1994 Jul; 267(1 Pt 1):E95-101. PubMed ID: 8048519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R; Kostyo JL; Colca JR
    Endocrinology; 1994 Feb; 134(2):608-13. PubMed ID: 8299559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.
    Cantello BC; Cawthorne MA; Cottam GP; Duff PT; Haigh D; Hindley RM; Lister CA; Smith SA; Thurlby PL
    J Med Chem; 1994 Nov; 37(23):3977-85. PubMed ID: 7966158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone hydrochloride inhibits cholesterol absorption and lowers plasma cholesterol concentrations in cholesterol-fed rats.
    Colca JR; Dailey CF; Palazuk BJ; Hillman RM; Dinh DM; Melchior GW; Spilman CH
    Diabetes; 1991 Dec; 40(12):1669-74. PubMed ID: 1756906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives.
    Reddy KA; Lohray BB; Bhushan V; Reddy AS; Rao Mamidi NV; Reddy PP; Saibaba V; Reddy NJ; Suryaprakash A; Misra P; Vikramadithyan RK; Rajagopalan R
    J Med Chem; 1999 Aug; 42(17):3265-78. PubMed ID: 10464013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and antihyperglycemic activity of novel 5-(naphthalenylsulfonyl)-2,4-thiazolidinediones.
    Zask A; Jirkovsky I; Nowicki JW; McCaleb ML
    J Med Chem; 1990 May; 33(5):1418-23. PubMed ID: 2329563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.